Brian Stolz
Equibles does not estimate personal net worth.
Get an email with a short summary when BridgeBio Pharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get BBIO alertsAbout Brian Stolz
Brian Stolz is recorded as COO at BridgeBio Pharma, Inc. (BBIO). The newest filing on record that lists Brian Stolz as COO at BridgeBio Pharma, Inc. (BBIO) is dated April 30, 2021. The proxy statement of BridgeBio Pharma, Inc. reports total compensation of $5,240,851 for Brian Stolz in fiscal 2020, including a base salary of $511,362. Disclosed compensation is on record for 2 fiscal years. BridgeBio Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BridgeBio Pharma, Inc. includes Neil Kumar (CEO and Board Member), Charles Homcy (Chairman and Board Member), Brian Stephenson (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2021
Company network
Leadership on record at BridgeBio Pharma, Inc.
- Neil Kumar CEO, Board Member
- Charles Homcy Chairman, Board Member
- Brian Stephenson CFO
- Thomas Trimarchi CFO, COO
- Brian C. Stephenson Chief Accounting Officer
- Ali J. Satvat Board Member
- Andrea Ellis Board Member
- Andrea J. Ellis Board Member
- Andrew W. Lo Board Member
- Douglas A. Dachille Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | BridgeBio Pharma, Inc. (BBIO) | Chief Operating Officer | $511,362 | $5,240,851 |
| 2019 | BridgeBio Pharma, Inc. (BBIO) | Chief Operating Officer | $146,780 | $8,146,313 |
Recent activity
No call appearances or filed executive changes recorded yet.